SEI Trust Company’s AstraZeneca AZN Stock Holding History

SEI Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$802K	Sell	11,230 -13,762	-55%	-$1.01M	0.01%	972
2014 Q2	$1.86M	Sell	24,992 -74,372	-75%	-$5.38M	0.02%	705
2014 Q1	$6.45M	Sell	99,364 -516	-0.5%	-$33.3K	0.06%	346
2013 Q4	$5.93M	Buy	99,880 +13,933	+16%	+$757K	0.06%	365
2013 Q3	$4.46M	Sell	85,947 -13,053	-13%	-$656K	0.05%	414
2013 Q2	$4.68M	Buy	+99,000	New	+$5.04M	0.06%	346

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SEI Trust Company's AZN Position: Q3 2014 in Review

SEI Trust Company reduced its AstraZeneca (AZN) stake by 55% in Q3 2014, selling an estimated $1.01M and leaving 11,230 shares worth $802K. The position accounts for 0.01% of the portfolio, ranked #972.

SEI Trust Company first reported a position in AZN in Q2 2013 and has held it in 6 quarters since. The position peaked at $6.45M in Q1 2014. 402 funds tracked by Wall St. Rank hold AZN as of Q3 2014.

SEI Trust Company held 11,230 shares of AstraZeneca worth $802K as of Q3 2014.
SEI Trust Company sold 13,762 AstraZeneca shares in Q3 2014, an estimated $1.01M.
AstraZeneca made up 0.01% of SEI Trust Company's portfolio in Q3 2014, its #972 holding.
SEI Trust Company first reported a position in AstraZeneca in Q2 2013 and has held it in 6 quarters since.
SEI Trust Company's AstraZeneca position peaked at $6.45M in Q1 2014.
402 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.